INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,829 studies · page 6 of 77

2018 / Systematic review and meta-analysis of RCTs

A meta-analysis of 21 randomized trials found resveratrol supplementation did not significantly alter overall serum lipid profiles.

A systematic review and meta-analysis of 21 RCTs examined the effect of resveratrol on serum lipid concentrations in adults using a random-effects model. Resveratrol did not significantly change total cholesterol (WMD = -0.08 mmol/l, 95% CI: -0.23, 0.08; P = .349), LDL-C (WMD: -0.04 mmol/l, 95% CI: -0.21, 0.12; P = .620), or HDL-C (WMD: -0.01 mmol/l, 95% CI: -0.04, 0.02; P = .269). While the effect on triacylglycerol was initially significant (WMD: 0.58 mmol/l, 95% CI: 0.34, 0.82; P < .0001), significance was lost after removing one study. Sex, age, BMI, resveratrol dosage, and intervention duration did not alter results, leading authors to conclude that resveratrol does not change lipid concentrations.

Haghighatdoost F, Hariri M Pharmacol Res, 2018. PMID 29305228

2018 / Meta-analysis of 141 cohort studies

Smoking just one cigarette per day was linked to roughly 40% to 50% of the excess risk of coronary heart disease and stroke seen with smoking 20 per day.

A meta-analysis of 141 prospective cohort studies evaluated the risk of coronary heart disease and stroke linked to light smoking (1 to 5 cigarettes/day). In fully adjusted analyses, men smoking one cigarette per day had pooled relative risks of 1.74 for coronary heart disease and 1.30 for stroke, representing 53% and 64% of the excess relative risk of smoking 20 cigarettes per day, respectively. For women smoking one cigarette daily, fully adjusted relative risks were 2.19 for coronary heart disease and 1.46 for stroke, representing 38% and 36% of the excess relative risk of smoking 20 cigarettes daily. The authors conclude that smoking only about one cigarette per day carries roughly half the excess cardiovascular disease risk of smoking 20 per day.

Shows an association, not proof of cause and effect.

Hackshaw A, Morris JK, Boniface S, et al. BMJ, 2018. PMID 29367388

2018 / Systematic review and meta-analysis

Plasma homocysteine levels were higher in intracerebral hemorrhage patients than healthy controls.

A meta-analysis of seven studies examined plasma homocysteine in 667 intracerebral hemorrhage patients and 1,821 ischemic stroke patients. Homocysteine concentrations were higher in patients with intracerebral hemorrhage than in healthy controls (SMD 0.59, 95% CI 0.51 to 0.68, P < 0.001). No significant difference appeared between intracerebral hemorrhage and ischemic stroke (SMD -0.03, 95% CI -0.13 to 0.06). Ethnicity did not alter these findings.

Zhou Z, Liang Y, Qu H, et al. Sci Rep, 2018. PMID 29416106

2018 / Meta-analysis of human intervention studies

Nut supplementation significantly improved flow-mediated dilation without significantly affecting endothelium-independent vasodilatation.

A meta-analysis evaluated 11 eligible articles with 13 trials involving 468 participants to assess the effect of oral nut supplementation on vasodilation. Overall, nut supplementation significantly increased flow-mediated dilation (WMD: 1.03%; 95% CI: 0.26-1.79%, P = 0.008), with significant heterogeneity among studies (P = 0.006) that might partly be explained by different nut types. No significant association between nut supplementation and endothelium-independent vasodilatation was observed in a fixed effect model (WMD: 1.10%, 95% CI: -0.19-2.38%, P = 0.09).

Huang Y, Zheng S, Wang T, et al. Vasa, 2018. PMID 29478408

2018 / Systematic review and practice guideline

Italian society dietary guidelines outline evidence on nutrition and stroke risk reduction.

An expert working group systematically evaluated nutritional risk factors for total, ischemic, and hemorrhagic stroke to inform national prevention guidelines. The review included 87 meta-analyses, alongside additional prospective cohorts, randomized trials, and case-control studies published between 2013 and 2016. The authors synthesized the evidence into 36 recommendations across nutrients, food groups, and overall dietary patterns to guide practical lifestyle modifications for primary stroke prevention.

Iacoviello L, Bonaccio M, Cairella G, et al. Nutr Metab Cardiovasc Dis, 2018. PMID 29482962

2018 / Systematic review and meta-analysis

Lower vitamin D status was linked to an increased risk of ischemic stroke in a meta-analysis.

A systematic review and meta-analysis of 19 studies pooled relative risk estimates comparing stroke risk between the lowest and highest categories of vitamin D. The overall pooled relative risk for stroke was 1.62 (95% CI: 1.34-1.96). Further analysis found vitamin D status was associated with ischemic stroke (RR = 2.45, 95% CI: 1.56-3.86), but not hemorrhagic stroke (RR = 2.50, 95% CI: 0.87-7.15).

Shows an association, not proof of cause and effect.

Zhou R, Wang M, Huang H, et al. Nutrients, 2018. PMID 29495586

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2018 / Systematic review of intervention studies

A systematic review suggests 160 minutes of weekly aerobic exercise for 6 months helps reduce erectile dysfunction related to cardiovascular risk factors.

A systematic review following PRISMA guidelines examined intervention studies published from 2006 through 2016 investigating physical activity as a treatment for erectile dysfunction (ED). Ten articles met inclusion criteria. The authors concluded that supervised aerobic exercise of moderate-to-vigorous intensity for 40 minutes, 4 times per week (160 minutes weekly for 6 months), contributes to decreasing erectile problems in men with ED linked to physical inactivity, obesity, hypertension, metabolic syndrome, or cardiovascular disease.

Gerbild H, Larsen CM, Graugaard C, et al. Sex Med, 2018. PMID 29661646

2018 / Systematic review and meta-analysis of controlled trials

The Portfolio dietary pattern significantly reduced LDL-C by ~17% and improved multiple cardiometabolic risk factors in hyperlipidemic participants.

A systematic review and meta-analysis of 7 controlled trial comparisons (439 participants with hyperlipidemia) evaluated the Portfolio dietary pattern on a background NCEP Step II diet versus an NCEP Step II diet alone. The Portfolio diet significantly reduced LDL-C by ~17% (MD, -0.73 mmol/L [95% CI, -0.89 to -0.56 mmol/L]) as well as non-HDL-C, apolipoprotein B, total cholesterol, triglycerides, systolic and diastolic blood pressure, C-reactive protein, and estimated 10-year CHD risk (all p < 0.05). No effect was seen on HDL-C or body weight. Certainty of evidence via GRADE was high for LDL-C and most lipid outcomes, and moderate for other outcomes.

Chiavaroli L, Nishi SK, Khan TA, et al. Prog Cardiovasc Dis, 2018. PMID 29807048

2018 / Meta-analysis of prospective cohorts

Lower fitness and higher BMI independently associate with greater cardiovascular mortality risk.

A meta-analysis of eight articles evaluated how cardiorespiratory fitness and BMI jointly related to cardiovascular mortality. Unfit individuals had two to three times the mortality risk across all BMI categories. Overweight-fit and obese-fit individuals showed 25% and 42% higher mortality risks, respectively, compared to normal weight-fit referents, though sensitivity analyses for five studies in the obese-fit group yielded non-significant changes.

Shows an association, not proof of cause and effect.

Barry VW, Caputo JL, Kang M Prog Cardiovasc Dis, 2018. PMID 29981352

2018 / Systematic review and meta-analysis of randomized controlled trials

Omega-3 intake showed little to no effect on cardiovascular mortality or events

A systematic review of 79 randomized trials including 112,059 adults assessed long-chain omega-3 and alpha-linolenic acid interventions. Increasing long-chain omega-3 had little or no effect on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04). Plant-based alpha-linolenic acid slightly reduced cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and coronary mortality (RR 0.95, 95% CI 0.72 to 1.26) based on low-quality evidence.

Abdelhamid AS, Brown TJ, Brainard JS, et al. Cochrane Database Syst Rev, 2018. PMID 30019766

2018 / Systematic review and meta-analysis of randomized controlled trials

Psyllium fiber supplementation significantly reduces LDL cholesterol, non-HDL cholesterol, and apolipoprotein B.

A systematic review and meta-analysis of 28 randomized controlled trials evaluated the effects of psyllium fiber (duration ≥3 weeks) on blood lipids in 1,924 participants. Supplementation with a median dose of ~10.2 g psyllium significantly lowered LDL cholesterol (MD = -0.33 mmol/L; 95% CI: -0.38, -0.27 mmol/L; P < 0.00001), non-HDL cholesterol (MD = -0.39 mmol/L; 95% CI: -0.50, -0.27 mmol/L; P < 0.00001), and apoB (MD = -0.05 g/L; 95% CI: -0.08, -0.03 g/L; P < 0.0001). Evidence quality assessed via GRADE was rated moderate for LDL and non-HDL cholesterol due to inconsistency, and high for apoB.

Jovanovski E, Yashpal S, Komishon A, et al. Am J Clin Nutr, 2018. PMID 30239559

2018 / Systematic review of randomized clinical trials

A systematic review found that beetroot juice supplementation might reduce blood pressure across healthy and hypertensive populations.

A systematic review of randomized clinical trials published from 2008 to 2018 evaluated the effect of beetroot juice intake on arterial blood pressure. Across 11 studies meeting the inclusion criteria, the review demonstrated that beetroot juice supplementation is a cost-effective strategy that might reduce blood pressure in different populations, likely through the nitrate/nitrite/nitric oxide pathway and secondary metabolites in Beta vulgaris. The authors note that several factors related to beetroot juice intake, such as gender and secondary metabolites, warrant further investigation.

Bonilla Ocampo DA, Paipilla AF, Marín E, et al. Biomolecules, 2018. PMID 30400267

2018 / Systematic review of controlled trials

A systematic review found plant-based diets were associated with improvements in well-being, quality of life, HbA1c, and weight in adults with diabetes.

This systematic review of 11 controlled trials (n=433; mean sample age 54.8 years) evaluated plant-based diet interventions targeting diabetes in adults. Plant-based diets were associated with significant improvement in emotional well-being, physical well-being, depression, quality of life, general health, HbA1c levels, weight, total cholesterol, and low-density lipoprotein cholesterol compared with diabetic associations' official guidelines and other comparator diets. The authors concluded that plant-based diets can significantly improve psychological health, quality of life, HbA1c levels, weight, and diabetes management.

Toumpanakis A, Turnbull T, Alba-Barba I BMJ Open Diabetes Res Care, 2018. PMID 30487971

2018 / Systematic review and meta-analysis of randomized controlled trials

Increasing long-chain omega-3 intake has little or no effect on mortality or cardiovascular events, while plant-based ALA may slightly reduce cardiovascular events.

This systematic review assessed 79 RCTs evaluating increased long-chain omega-3 (LCn3) or alpha-linolenic acid (ALA) for cardiovascular outcomes. High-quality evidence showed little or no effect of LCn3 on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04), though LCn3 reduced triglycerides by ~15% in a dose-dependent manner. Increasing ALA probably made little difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20), but low-quality evidence suggested it may slightly reduce cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and arrhythmia (RR 0.79, 95% CI 0.57 to 1.10).

Abdelhamid AS, Brown TJ, Brainard JS, et al. Cochrane Database Syst Rev, 2018. PMID 30521670

2018 / Meta-analysis of observational studies

A vegan diet was associated with a more favourable cardiometabolic profile compared to an omnivorous diet in most countries.

A meta-analysis of 40 observational studies assessed cardiometabolic risk factors in 12,619 vegans and 179,630 omnivores. Compared to controls, vegans had lower body mass index (-1.72 kg/m2, CI -2.30 to -1.16), waist circumference (-2.35 cm, CI -3.93 to -0.76), LDL cholesterol (-0.49 mmol/L, CI -0.62 to -0.36), triglycerides (-0.14 mmol/L, CI -0.24 to -0.05), fasting blood glucose (-0.23 mmol/L, CI -0.35 to -0.10), systolic blood pressure (-2.56 mmHg, CI -4.66 to -0.45), and diastolic blood pressure (-1.33 mmHg, CI -2.67 to -0.02; p<0.0001 for all). In several large studies from Taiwan, however, a vegan diet was not associated with favourable cardio-metabolic risk factors compared to control diets.

Shows an association, not proof of cause and effect.

Benatar JR, Stewart RAH PLoS One, 2018. PMID 30571724

2017 / Systematic review and meta-analysis of observational studies

Vegetarian and vegan diets were linked to lower ischemic heart disease and cancer incidence.

A meta-analysis of 86 cross-sectional and 10 prospective cohort studies evaluated vegetarian and vegan diets against omnivorous diets. Prospective cohorts linked vegetarian diets to lower risk of ischemic heart disease incidence or mortality (RR 0.75, 95% CI 0.68 to 0.82) and total cancer incidence (RR 0.92, 95% CI 0.87 to 0.98), but found no link to all-cause or cardiovascular mortality. Vegan diets were associated with lower total cancer incidence (RR 0.85, 95% CI 0.75 to 0.95).

Shows an association, not proof of cause and effect.

Dinu M, Abbate R, Gensini GF, et al. Crit Rev Food Sci Nutr, 2017. PMID 26853923

2017 / Meta-analysis of prospective cohorts

Cheese intake was associated with lower risks of cardiovascular disease, CHD, and stroke.

A meta-analysis of 15 prospective studies evaluated cheese consumption and cardiovascular outcomes. High versus low cheese intake was linked to lower relative risks of total cardiovascular disease (RR 0.90, 95% CI 0.82-0.99; 8,076 events), coronary heart disease (RR 0.86, 95% CI 0.77-0.96; 7,631 events), and stroke (RR 0.90, 95% CI 0.84-0.97; 10,449 events). Nonlinear analyses showed the greatest risk reductions at approximately 40 grams per day.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Chen GC, Wang Y, Tong X, et al. Eur J Nutr, 2017. PMID 27517544

2017 / Systematic review and meta-analysis of cohort studies

White rice intake was associated with total chronic disease risk in women.

A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).

Shows an association, not proof of cause and effect.

Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106

2017 / Meta-analysis of randomized controlled trials

Blueberry supplementation did not significantly improve blood pressure in clinical trials

A meta-analysis of 6 randomized controlled trials with 204 participants examined blueberry supplementation. The intervention showed no significant effect on systolic blood pressure (mean difference -0.28 mmHg, 95% CI: -1.11 to 0.56) or diastolic blood pressure (mean difference -0.5 mmHg, 95% CI: -1.24 to 0.24). Overall, findings did not demonstrate clinical efficacy for improving blood pressure.

Zhu Y, Sun J, Lu W, et al. J Hum Hypertens, 2017. PMID 27654329

2017 / Meta-analysis of randomized controlled trials

Higher red meat intake did not affect cardiovascular risk factors in trial meta-analysis

A meta-analysis of 24 randomized controlled trials in adults aged 19 and older compared red meat intake of at least 0.5 versus under 0.5 servings daily. Red meat intake did not affect postintervention blood lipids, lipoproteins, or blood pressure (P > 0.05). Across all subjects, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and diastolic blood pressure decreased over time.

NANO counterpoint →

O'Connor LE, Kim JE, Campbell WW Am J Clin Nutr, 2017. PMID 27881394

2017 / Systematic review and dose-response meta-analysis of prospective studies

Higher fruit and vegetable intake was linked to lower risks of cardiovascular disease, total cancer, and all-cause mortality.

A systematic review and dose-response meta-analysis evaluated 95 prospective studies examining fruit and vegetable intake in relation to cardiovascular disease, cancer, and mortality. Per 200 g/day of combined fruit and vegetables, summary relative risks were 0.92 (95% CI: 0.90-0.94) for coronary heart disease, 0.84 (95% CI: 0.76-0.92) for stroke, 0.92 (95% CI: 0.90-0.95) for cardiovascular disease, 0.97 (95% CI: 0.95-0.99) for total cancer, and 0.90 (95% CI: 0.87-0.93) for all-cause mortality. Reductions in risk were observed up to 800 g/day for all outcomes except cancer (up to 600 g/day). Specific inverse associations with cardiovascular disease and mortality were reported for apples/pears, citrus fruits, green leafy vegetables, cruciferous vegetables, and salads.

Shows an association, not proof of cause and effect.

Aune D, Giovannucci E, Boffetta P, et al. Int J Epidemiol, 2017. PMID 28338764

2017 / Meta-analysis of prospective cohorts

Dairy showed neutral associations with mortality and CVD, with attenuated fermented dairy signals

In a meta-analysis of 29 prospective cohort studies, intake of total dairy and milk was not associated with mortality, CHD, or CVD. Total fermented dairy was inversely linked to mortality (RR 0.98, 95% CI 0.97-0.99) and CVD risk (RR 0.98, 95% CI 0.97-0.99) per 20 g/day, and cheese to lower CVD risk (RR 0.98, 95% CI 0.95-1.00) per 10 g/day. However, these marginal inverse associations attenuated in sensitivity analyses when removing one large Swedish study.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Guo J, Astrup A, Lovegrove JA, et al. Eur J Epidemiol, 2017. PMID 28374228

2017 / Systematic review and meta-analysis of RCTs

Niacin therapy did not reduce mortality or cardiovascular events in people with or at risk of CVD and increased side effects.

A systematic review and meta-analysis of 23 RCTs involving 39,195 participants evaluated niacin monotherapy or add-on therapy (median dose 2 g/day, median duration 11.5 months). Niacin did not reduce overall mortality (RR 1.05, 95% CI 0.97 to 1.12), cardiovascular mortality (RR 1.02, 95% CI 0.93 to 1.12), non-cardiovascular mortality (RR 1.12, 95% CI 0.98 to 1.28), fatal or non-fatal myocardial infarctions (RR 0.93, 95% CI 0.87 to 1.00), or strokes (RR 0.95, 95% CI 0.74 to 1.22). Participants receiving niacin were significantly more likely to discontinue treatment due to side effects compared to control (RR 2.17, 95% CI 1.70 to 2.77).

Schandelmaier S, Briel M, Saccilotto R, et al. Cochrane Database Syst Rev, 2017. PMID 28616955